{"id":"lithium-plus-valproate","safety":{"commonSideEffects":[{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Polyuria/polydipsia"},{"rate":null,"effect":"Cognitive impairment"}]},"_chembl":{"chemblId":"CHEMBL433","moleculeType":"Small molecule","molecularWeight":"166.20"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lithium inhibits inositol monophosphatase and glycogen synthase kinase-3 (GSK-3), affecting intracellular signaling cascades and neuroprotective pathways. Valproate inhibits histone deacetylase and enhances GABAergic neurotransmission while modulating gene expression. The combination is used in bipolar disorder to achieve synergistic mood stabilization.","oneSentence":"Lithium and valproate together modulate neuronal signaling and gene expression through distinct pathways to stabilize mood and reduce manic or depressive episodes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:52:40.275Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bipolar disorder (acute mania or maintenance treatment)"},{"name":"Treatment-resistant bipolar depression"}]},"trialDetails":[{"nctId":"NCT06929273","phase":"PHASE3","title":"A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-07-18","conditions":"Bipolar Disorder Type I With Mania","enrollment":450},{"nctId":"NCT07140913","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Mania, Bipolar Disorder","enrollment":424},{"nctId":"NCT06993662","phase":"PHASE1","title":"The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rakitzi, Stavroula","startDate":"2025-06-02","conditions":"Anxiety, Depression, Obsessive-compulsive Disorder","enrollment":107},{"nctId":"NCT07047651","phase":"PHASE4","title":"Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.","status":"RECRUITING","sponsor":"Dr. Stavroula Rakitzi","startDate":"2025-06-04","conditions":"Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder","enrollment":40},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT05973786","phase":"PHASE3","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-02-11","conditions":"Bipolar Depression","enrollment":418},{"nctId":"NCT06729541","phase":"NA","title":"Development and Application of Precision Treatment Strategies for Common Mental Disorders","status":"RECRUITING","sponsor":"Peking University","startDate":"2024-11-11","conditions":"Depression - Major Depressive Disorder, Schizophrenia Disorders, Bipolar Disorder (BD)","enrollment":600},{"nctId":"NCT00581009","phase":"PHASE1, PHASE2","title":"The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2001-05-30","conditions":"Major Depressive Disorder, Bipolar Disorder","enrollment":49},{"nctId":"NCT04218981","phase":"NA","title":"Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders","status":"COMPLETED","sponsor":"Central South University","startDate":"2020-01-15","conditions":"Common Mental Disorder","enrollment":200},{"nctId":"NCT02600507","phase":"PHASE3","title":"Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression","status":"COMPLETED","sponsor":"Intra-Cellular Therapies, Inc.","startDate":"2016-03-07","conditions":"Bipolar Depression","enrollment":529},{"nctId":"NCT00261443","phase":"PHASE4","title":"A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2005-09","conditions":"Bipolar Disorder","enrollment":1270},{"nctId":"NCT02213887","phase":"PHASE4","title":"Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2014-09","conditions":"Psychotic Disorders, Gastroesophageal Reflux","enrollment":""},{"nctId":"NCT00312494","phase":"PHASE3","title":"3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-04","conditions":"Bipolar Disorder","enrollment":680},{"nctId":"NCT00483548","phase":"PHASE3","title":"Adjunctive Ziprasidone in the Treatment of Bipolar I Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Bipolar Disorder, Depression, Bipolar","enrollment":298},{"nctId":"NCT02870283","phase":"PHASE4","title":"Cost- Effectiveness and Quality of Life Assessment in Mood Disorder","status":"COMPLETED","sponsor":"Federal University of Rio Grande do Sul","startDate":"2010-05","conditions":"Bipolar Disorder","enrollment":107},{"nctId":"NCT01588457","phase":"PHASE4","title":"Sequential Multiple Assignment Treatment for Bipolar Disorder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2011-06","conditions":"Bipolar I Disorder, Bipolar II Disorder","enrollment":112},{"nctId":"NCT03204500","phase":"PHASE2","title":"Dual Treatment With Lithium and Valproate in ALS.","status":"COMPLETED","sponsor":"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez","startDate":"2016-05","conditions":"Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Sporadic","enrollment":43},{"nctId":"NCT00643123","phase":"PHASE4","title":"Allopurinol Add-on Treatment for Refractory Mania","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2007-09","conditions":"Bipolar Disorder, Mixed Mania, Treatment-Resistant Mania","enrollment":40},{"nctId":"NCT00254488","phase":"PHASE4","title":"Treatment of Bipolar Mania in Older Adults","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2005-11","conditions":"Bipolar Disorder, Mania","enrollment":224},{"nctId":"NCT00183443","phase":"PHASE3","title":"Treatment of Mania Symptoms With Drug Therapy","status":"COMPLETED","sponsor":"Palo Alto Veterans Institute for Research","startDate":"2005-02","conditions":"Bipolar Disorder, Schizophrenia","enrollment":75},{"nctId":"NCT00194129","phase":"PHASE3","title":"Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"1997-11","conditions":"Bipolar Disorder","enrollment":31},{"nctId":"NCT00667745","phase":"PHASE4","title":"Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2008-04","conditions":"Bipolar Disorder","enrollment":283},{"nctId":"NCT00000439","phase":"PHASE2","title":"Drug Treatment for Alcoholics With Bipolar Disorder","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2000-10","conditions":"Alcoholism, Bipolar Disorder","enrollment":72},{"nctId":"NCT02593643","phase":"EARLY_PHASE1","title":"Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-01","conditions":"Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder","enrollment":9},{"nctId":"NCT01463111","phase":"NA","title":"Decision-Making in Bipolar Disorder","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-05","conditions":"Bipolar Disorder","enrollment":37},{"nctId":"NCT01784666","phase":"PHASE2","title":"Adjunctive Isradipine for the Treatment of Bipolar Depression","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2013-02","conditions":"Bipolar Disorder","enrollment":2},{"nctId":"NCT00562861","phase":"PHASE2, PHASE3","title":"Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2007-11","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":119},{"nctId":"NCT00063362","phase":"PHASE3","title":"Combination Therapy for the Treatment of Bipolar Disorders","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2002-02","conditions":"Bipolar Disorder","enrollment":49},{"nctId":"NCT00240110","phase":"PHASE1, PHASE2","title":"Valproate Efficacy in Cocaine-Bipolar Comorbidity","status":"COMPLETED","sponsor":"University of Miami","startDate":"2006-03","conditions":"Bipolar Disorder, Cocaine Dependence","enrollment":152},{"nctId":"NCT01358357","phase":"PHASE3","title":"Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2011-06","conditions":"Bipolar I Disorder","enrollment":965},{"nctId":"NCT01575561","phase":"PHASE3","title":"This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2012-06","conditions":"Bipolar I Disorder","enrollment":377},{"nctId":"NCT01467700","phase":"PHASE3","title":"Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder","status":"TERMINATED","sponsor":"Takeda","startDate":"2011-12","conditions":"Acute Depressive Episode","enrollment":490},{"nctId":"NCT01689389","phase":"","title":"Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-12","conditions":"Schizophrenia, Bipolar Episodes","enrollment":2292},{"nctId":"NCT01977300","phase":"PHASE3","title":"Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2003-01","conditions":"Bipolar I Disorder","enrollment":159},{"nctId":"NCT00221975","phase":"PHASE3","title":"Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2002-07","conditions":"Bipolar Disorder","enrollment":98},{"nctId":"NCT00332098","phase":"PHASE3","title":"Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2006-08","conditions":"Bipolar Disorder","enrollment":145},{"nctId":"NCT00868452","phase":"PHASE3","title":"Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2009-04","conditions":"Bipolar Depression","enrollment":348},{"nctId":"NCT00665366","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2008-06","conditions":"Bipolar Disorder Mania","enrollment":493},{"nctId":"NCT01284517","phase":"PHASE3","title":"Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2010-11","conditions":"Bipolar Depression","enrollment":356},{"nctId":"NCT00257972","phase":"PHASE3","title":"Study of Aripiprazole in Patients With Bipolar I Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2004-10","conditions":"Bipolar Disorder","enrollment":400},{"nctId":"NCT00976794","phase":"PHASE4","title":"Efficacy of Combined Treatment for Young Bipolar I Disorder","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-01","conditions":"Bipolar I Disorder","enrollment":40},{"nctId":"NCT00057681","phase":"PHASE3","title":"Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2003-02","conditions":"Bipolar Disorder","enrollment":379},{"nctId":"NCT00114686","phase":"PHASE3","title":"Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-01","conditions":"Bipolar I Disorder, Alcohol Dependence","enrollment":350},{"nctId":"NCT00857584","phase":"PHASE3","title":"Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-05","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":27},{"nctId":"NCT00309686","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-04","conditions":"Affective Psychosis, Bipolar, Bipolar Disorder, Mania","enrollment":300},{"nctId":"NCT01075126","phase":"PHASE4","title":"Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder","status":"WITHDRAWN","sponsor":"Lawson, William B., M.D., PhD, DFAPA","startDate":"2006-12","conditions":"Bipolar Disorder","enrollment":50},{"nctId":"NCT01000402","phase":"PHASE4","title":"Juvenile Bipolar Disorder Outpatient Program","status":"UNKNOWN","sponsor":"Federal University of Rio Grande do Sul","startDate":"2008-02","conditions":"Bipolar Disorder, Attention Deficit Disorder With Hyperactivity","enrollment":150},{"nctId":"NCT00107731","phase":"PHASE3","title":"Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-04","conditions":"Bipolar I Disorder","enrollment":710},{"nctId":"NCT00081380","phase":"PHASE3","title":"Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-03","conditions":"Bipolar Disorder","enrollment":710}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"lithium plus valproate","genericName":"lithium plus valproate","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lithium and valproate together modulate neuronal signaling and gene expression through distinct pathways to stabilize mood and reduce manic or depressive episodes. Used for Bipolar disorder (acute mania or maintenance treatment), Treatment-resistant bipolar depression.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}